PRH — Livingstone Health Holdings Income Statement
0.000.00%
- SG$15.36m
- SG$15.55m
- SG$29.29m
Annual income statement for Livingstone Health Holdings, fiscal year end - March 31st, SGD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 34.1 | 32.9 | 25.4 | 27.6 | 29.3 |
| Cost of Revenue | |||||
| Gross Profit | 27.3 | 27.3 | 20.2 | 22 | 22.9 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Operating Interest Expense / Income | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 29.9 | 31.1 | 28.1 | 27.6 | 29.8 |
| Operating Profit | 4.25 | 1.8 | -2.71 | 0.07 | -0.493 |
| Net Income Before Taxes | 4.25 | 1.8 | -2.71 | 0.07 | -0.493 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 3.54 | 1.29 | -2.9 | 0.167 | -0.496 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 3.02 | 0.723 | -2.87 | 0.556 | 0.223 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 3.02 | 0.723 | -2.87 | 0.556 | 0.223 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.009 | 0.002 | -0.005 | 0.001 | 0 |
| Dividends per Share |